Sharemaestro company-news research for Oscar Health Inc (OSCR), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NYSE
United States
Provisional evidence
Company news sentiment
Latest OSCR news and sentiment
Oscar Health Inc
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
57 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone65/100
→
Published 30-day score55/100
Latest source headline
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History
Yahoo! Finance Canada · 10 Oct 2026 23:57
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
57 current stories are mapped specifically to OSCR.
The score uses 15 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.381.
Confidence is 28/100, below the threshold for a firm score.
55/100
News scoreEarly balanced news score
28/100
Confidencethin evidence
94%/100
Company news57 company stories
89/100
Story agreement11/100 difference
News history
Daily score and story count over 30 days
14 Sep29 Sep13 Oct
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence8
0.381 after freshness weightingSource breadth100
15 independent publishersCompany relevance94
share tied directly to this companyFreshness26
recency-weighted evidenceAgreement89
how closely stories agreePublisher mix75
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks16 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
17 Apr14 Jul09 Oct
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
09 Oct 202654USD 33.37+7.9%
02 Oct 202652USD 30.94+4.5%
25 Sep 202656USD 29.6-7.9%
18 Sep 202654USD 32.13-2.0%
11 Sep 202654USD 32.77+1.6%
04 Sep 202656USD 32.25+5.8%
28 Aug 202654USD 30.47-4.9%
21 Aug 202655USD 32.04-2.2%
Provisional evidence
News subjects
What is shaping the score
Market update5027 stories · 47%
Earnings5523 stories · 40%
Guidance654 stories · 7%
Analyst action712 stories · 4%
Deals and strategy501 stories · 2%
Source mix
Where the evidence comes from
Zacks5211 stories · 19%
Simply Wall Street675 stories · 9%
MarketBeat495 stories · 9%
finance.yahoo.com384 stories · 7%
Simply Wall St.614 stories · 7%
Yahoo! Finance Canada504 stories · 7%
MT Newswires603 stories · 5%
Recurring subjects
Subjects appearing most often
Earnings23Healthcare15Insurance12Earnings Per Share7Earnings Growth6Consensus Estimate6Financial Markets5Estimate Revisions5Guidance4AI4
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
30 Jul50 neutral13 Oct 18:28
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Oct 18:28 | 53 | -1 | 28/100 (-5) | 57 (-4) | Provisional |
| 10 Oct 23:59 | 54 | +0 | 33/100 (-4) | 61 (-1) | Provisional |
| 08 Oct 23:59 | 54 | -1 | 37/100 (-3) | 62 (-3) | Measured |
| 07 Oct 23:59 | 55 | +3 | 40/100 (+16) | 65 (+5) | Measured |
| 06 Oct 23:59 | 52 | +0 | 24/100 (-1) | 60 (+3) | Provisional |
| 05 Oct 23:59 | 52 | +0 | 25/100 (-7) | 57 (-4) | Provisional |
| 01 Oct 23:59 | 52 | -1 | 32/100 (+3) | 61 (+1) | Provisional |
| 30 Sep 23:59 | 53 | +0 | 29/100 (-2) | 60 (-2) | Provisional |
Evidence behind the direction
What drives this reading?
Shares of weighted directional evidence in 57 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
Which subjects lean each way
A subject can carry both supportive and cautious news.
SubjectCautious ← 0 → Constructive
Guidance2 stories
0.0%60.8%
Earnings11 stories
8.9%29.4%
Analyst action2 stories
0.1%0.5%
Market update2 stories
0.3%0.1%
Each side uses the same scale: 0–60.8% of the retained directional evidence.
Where the influence comes from
39.9%largest publisher shareA concentrated reading can depend heavily on one publisher.
Publisher groups follow the scoring rules. Company disclosures share one group; syndicated stories are consolidated before weighting.
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 10 Oct 2026 23:57
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 2.8d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?
Oscar Health's OSCR growth prospects remain closely linked to the expansion of the Affordable Care Act (ACA) marketplace. However, the key question is whether its recent momentum reflects a lasting competitive advantage or continued reliance on favorable policy and market conditions. Enha…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Oscar Health's OSCR growth prospects remain closely linked to the expansion of the Affordable Care Act (ACA) marketplace. However, the key question is whether its recent momentum reflects a lasting competitive advantage or continued reliance on favorable policy and market conditions. Enhanced premium subsidies have historically improved affordability and supported marketplace enrollment, enabling Oscar to attract members through its technology-driven platform, consumer-focused offerings and expanding provider relationships. A growing membership base could strengthen operating leverage by sprea
- Published
- 08 Oct 2026 16:03
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 5.1d old
- Text assessed
- Available headline and article text
- Duplicates
- 3 consolidated
EarningsGovernment Sponsored ProgramsHealthcare
—Unscored
EarningsNot used in direction
Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors
Oscar Health, Inc. (OSCR) ended the recent trading session at $32.91, demonstrating a +1.76% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Meanwhile, the Dow experienced a drop of 0.66%, and the technology-dominated Nasdaq saw a d…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Oscar Health, Inc. (OSCR) ended the recent trading session at $32.91, demonstrating a +1.76% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Meanwhile, the Dow experienced a drop of 0.66%, and the technology-dominated Nasdaq saw a decrease of 0.22%. Prior to today's trading, shares of the company had lost 2.03% was narrower than the Finance sector's loss of 4.09% and lagged the S&P 500's gain of 1.4%. Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The
- Published
- 07 Oct 2026 21:15
- News subject
- Earnings
- Why this score
- Large negative market reaction
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 5.9d old
- Text assessed
- Stored article
- Duplicates
- 2 consolidated
Consensus EstimateEarningsEarnings GrowthEstimate RevisionsFinancialsInsurance
66/100 tone
Oscar Health recently reported past second-quarter 2026 results with earnings from operations of US$1.10 billion, net income of US$1.00 billion, and revenue of US$4.90 billion, and raised its full-year 2026 outlook for both earnings and revenue. A distinctive angle is Oscar Health's empha…
19.1% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Oscar Health recently reported past second-quarter 2026 results with earnings from operations of US$1.10 billion, net income of US$1.00 billion, and revenue of US$4.90 billion, and raised its full-year 2026 outlook for both earnings and revenue. A distinctive angle is Oscar Health's emphasis on using its AI-driven platform to improve claims accuracy, manage costs, and support membership growth, positioning technology as a core driver of its operating performance. Next, we'll explore how Oscar Health's AI-fueled operational gains and higher 2026 guidance could influence its longer-term investme
- Published
- 07 Oct 2026 20:11
- News subject
- Earnings
- Why this score
- Guidance raised
- Company focus
- Shared story · 78%
- How it is used
- Direct company coverage
- Story strength
- Medium · 50/100
- 30-day weight
- 19.1% of directional evidence · 5.9d old
- Text assessed
- Stored article
- Duplicates
- 2 consolidated
AIEarningsGuidanceHealthcareNet IncomeRevenue Growth
75/100 tone
39.9% of directional evidence
High story strength
Scoring detailsDirect company coverage
- Published
- 07 Oct 2026 15:51
- News subject
- Guidance
- Why this score
- Guidance raised
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- High · 64/100
- 30-day weight
- 39.9% of directional evidence · 6.1d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. $OSCR Stock Sold by Glynn Capital Management LLC
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 07 Oct 2026 11:08
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 6.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
57/100 tone
20.8% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 07 Oct 2026 00:41
- News subject
- Guidance
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 44/100
- 30-day weight
- 20.8% of directional evidence · 6.7d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health (OSCR) Among 22 Financial Sector Stocks with A+ Gro
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 06 Oct 2026 12:19
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 7.3d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
GuidanceNot used in direction
Oscar Health (NYSE:OSCR) Stock Forecast & Analyst Predictions
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 06 Oct 2026 07:00
- News subject
- Guidance
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 7.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) latest stock news and headlines
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 06 Oct 2026 06:49
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 7.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 05 Oct 2026 17:45
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 8.0d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
Oscar Health Trading at a Premium: Why Should You Still Buy It?
Shares of Oscar Health OSCR are trading at a price-to-book multiple of 4.65, higher than the industry average of 2.65 and the median of 3.97 over three years. It has a Value Score of B. The premium valuation likely reflects Oscar's technology-led, consumer-centric business model, along wi…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Shares of Oscar Health OSCR are trading at a price-to-book multiple of 4.65, higher than the industry average of 2.65 and the median of 3.97 over three years. It has a Value Score of B. The premium valuation likely reflects Oscar's technology-led, consumer-centric business model, along with its longer-term margin expansion potential supported by improving medical loss ratio (MLR) and SG&A ratios. Oscar is a leading healthcare technology company built around a full-stack technology platform. It is well-positioned for sustained growth as it strengthens its presence in the expanding U.S. individu
- Published
- 05 Oct 2026 17:38
- News subject
- Earnings
- Why this score
- Margin Expansion
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 8.0d old
- Text assessed
- Stored article
- Duplicates
- 3 consolidated
Balance SheetConsensus EstimateEarningsEarnings GrowthHealthcareIndividual Insurance Market
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) latest stock news and headlines
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 01 Oct 2026 21:30
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 11.9d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR) closed the most recent trading day at $29.90, moving -3.05% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.2%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Oscar Health, Inc. (OSCR) closed the most recent trading day at $29.90, moving -3.05% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.2%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.04%. The stock of company has risen by 1.68% in the past month, leading the Finance sector's loss of 4.84% and the S&P 500's loss of 0.35%. Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projecte
- Published
- 01 Oct 2026 21:00
- News subject
- Earnings
- Why this score
- Positive financial language
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 11.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 3 consolidated
Analyst EstimatesConsensus EstimateEarningsEarnings GrowthEarnings Per ShareEstimate Revisions
42/100 tone
0.3% of directional evidence
Low story strength
Scoring detailsDirect company coverage
- Published
- 01 Oct 2026 07:16
- News subject
- Market update
- Why this score
- Institutional or insider selling
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Low · 31/100
- 30-day weight
- 0.3% of directional evidence · 12.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
9VY Forecast — Price Target — Prediction for 2027
This article provides a forecast for Oscar Health, Inc. Class A stock (9VY) for 2027, including price targets from analysts and historical financial data. It details the company's market capitalization, volatility, past earnings performance, and upcoming earnings report date. The article …
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
This article provides a forecast for Oscar Health, Inc. Class A stock (9VY) for 2027, including price targets from analysts and historical financial data. It details the company's market capitalization, volatility, past earnings performance, and upcoming earnings report date. The article also addresses frequently asked questions about the stock, such as its ticker, market cap, revenue, net income, and how to purchase shares.
- Published
- 30 Sep 2026 12:28
- News subject
- Earnings
- Why this score
- No clear directional signal in the available text
- Company focus
- Company discussed · 86%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.2d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinancial MarketsLife Sciences
—Unscored
Market updateNot used in direction
Does Medical Loss Ratio Discipline Change The Bull Case For Oscar Health Stock (OSCR)?
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 30 Sep 2026 00:45
- News subject
- Market update
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.7d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 29 Sep 2026 11:12
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 14.3d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (NYSE:OSCR) Stock Now Rated "Hold" by Sell-Side Analysts
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 29 Sep 2026 06:25
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 14.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
Is Oscar Health (OSCR) Cheap After Its EPS Roadmap And New Product Push?
Oscar Health (OSCR) has drawn fresh attention after management highlighted a roadmap to higher earnings per share, tied to medical loss ratio discipline and new offerings such as the Lucy Healthcare Marketplace and AI powered tools. Recent trading has been choppy for Oscar Health, with th…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Oscar Health (OSCR) has drawn fresh attention after management highlighted a roadmap to higher earnings per share, tied to medical loss ratio discipline and new offerings such as the Lucy Healthcare Marketplace and AI powered tools. Recent trading has been choppy for Oscar Health, with the share price slipping 5.40% over seven days and 2.86% over 30 days. However, a 3.79% 90 day share price return and a 97.73% year to date share price return suggest momentum has been building over a longer stretch, supported by a 54.73% one year total shareholder return and a very large 3 year total shareholde
- Published
- 28 Sep 2026 11:11
- News subject
- Earnings
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 3 consolidated
Balance SheetEarningsEarnings Per ShareGrowthHealthcareInsurance
—Unscored
Market updateNot used in direction
Form 4 Oscar Health Inc For: 28 September By Investing.com
This article from Investing.com reports on a Form 4 filing for Oscar Health Inc. on September 28. It includes the stock symbol OSCR, which showed a gain of 3.48% at the time of publication. The brief report indicates a financial transaction or disclosure related to the company on that dat…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
This article from Investing.com reports on a Form 4 filing for Oscar Health Inc. on September 28. It includes the stock symbol OSCR, which showed a gain of 3.48% at the time of publication. The brief report indicates a financial transaction or disclosure related to the company on that date.
- Published
- 28 Sep 2026 06:32
- News subject
- Market update
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 3 consolidated
FinanceFinancial MarketsLife Sciences
—Unscored
Market updateNot used in direction
Oscar Health (OSCR) Shares Moved, What Is Catching Investors' Attention?
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 28 Sep 2026 04:48
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.6d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path
Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more importa…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more important for anyone trying to judge what they are actually paying for. Over the past 3 years the stock has delivered a very large gain of about 4.3x, which puts a lot of weight on whether the underlying earnings can support that kind of valuation. Management is outlining a path to higher earnings per share, supporte
- Published
- 27 Sep 2026 13:08
- News subject
- Earnings
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 16.2d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsEarnings Per ShareHealthcareInsuranceShare PriceValuation
42/100 tone
Oscar Health director Vanessa Wittman sold 25,000 shares of the company's Class A Common Stock for $806,000 on September 18, 2026, as part of a Rule 10b5-1 trading plan. Following the transaction, Wittman directly holds 112,121 shares. The sale occurred after Oscar Health reported strong …
7% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Oscar Health director Vanessa Wittman sold 25,000 shares of the company's Class A Common Stock for $806,000 on September 18, 2026, as part of a Rule 10b5-1 trading plan. Following the transaction, Wittman directly holds 112,121 shares. The sale occurred after Oscar Health reported strong Q2 2026 results and raised its 2026 guidance, with analysts like Piper Sandler and BofA Securities adjusting price targets.
- Published
- 27 Sep 2026 12:10
- News subject
- Earnings
- Why this score
- Institutional or insider selling
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 36/100
- 30-day weight
- 7% of directional evidence · 16.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinancial MarketsLife Sciences
—Unscored
Market updateNot used in direction
Oscar Health (OSCR) Stock Analysis Report | Financials & Insights
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 27 Sep 2026 07:00
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 16.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
57/100 tone
<0.1% of directional evidence
Low story strength
Scoring detailsDirect company coverage
- Published
- 27 Sep 2026 01:31
- News subject
- Market update
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Low · 29/100
- 30-day weight
- <0.1% of directional evidence · 16.7d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health (OSCR) Stock May Be Undervalued Following Its AI Marketplace Launch
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 26 Sep 2026 20:42
- News subject
- Market update
- Why this score
- Positive valuation view
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 16.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 25 Sep 2026 07:24
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 18.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
57/100 tone
Oscar Health OSCR has returned to profitability after three consecutive quarters of losses, posting operating profits in both the first and second quarters of 2026. Rapid Affordable Care Act (ACA) membership growth, higher premiums, improved medical costs and tighter expense control drove…
2% of directional evidence
Low story strength
Scoring detailsDirect company coverage
Oscar Health OSCR has returned to profitability after three consecutive quarters of losses, posting operating profits in both the first and second quarters of 2026. Rapid Affordable Care Act (ACA) membership growth, higher premiums, improved medical costs and tighter expense control drove the turnaround. Membership reached 2.96 million as of June 30, up from 2.03 million a year earlier. Second-quarter revenues climbed 70% to $4.88 billion, while the medical loss ratio improved to 79.2% from 91.1%. A lower selling, general and administrative expense ratio also helped Oscar generate $388.6 milli
- Published
- 23 Sep 2026 17:58
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Shared story · 78%
- How it is used
- Direct company coverage
- Story strength
- Low · 30/100
- 30-day weight
- 2% of directional evidence · 20.0d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
Consensus EstimateEarningsEarnings Per ShareGuidanceHealthcareMembership Growth
74/100 tone
Investors might want to bet on Oscar Health, Inc. (OSCR), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of …
0.5% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Investors might want to bet on Oscar Health, Inc. (OSCR), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Individual investors often find it hard to make decisions based on rating upg
- Published
- 23 Sep 2026 16:00
- News subject
- Analyst action
- Why this score
- Analyst upgrade
- Company focus
- Shared story · 78%
- How it is used
- Direct company coverage
- Story strength
- Medium · 45/100
- 30-day weight
- 0.5% of directional evidence · 20.1d old
- Text assessed
- Stored article
- Duplicates
- 3 consolidated
EarningsEarnings EstimateEstimate RevisionsInstitutional InvestorsPrice TargetRatings
Earlier company news
OSCR news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 127 older OSCR headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to OSCR, but the headline and available text are not mainly about Oscar Health Inc. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of OSCR sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.